Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Webster

Showing results (921-930 of 996) with videos related to

Pageof 100
Sort By:
Ejhaem|October 17, 2024
A phase 1 trial of venetoclax in combination with liposomal vincristine in patients with relapsed or refractory B-cell or T-cell acute lymphoblastic leukemia: Results from the ECOG-ACRIN EA9152 protocolNeil D Palmisiano, Ju-Whei Lee, David F Claxton, et al.
Current Oncology (Toronto, Ont.)|May 15, 2023
Integrating Tobacco Use Assessment and Treatment in the Oncology Setting: Quality Improvement Results from the Georgetown Lombardi Smoking Treatment and Recovery ProgramKathryn L Taylor, Marguerite A Webster, Joanna G Philips, et al.
Nature Biotechnology|June 4, 2002
Field and pulping performances of transgenic trees with altered lignificationGilles Pilate, Emma Guiney, Karen Holt, et al.
BMC Immunology|February 8, 2008
Screening of functional and positional candidate genes in families with common variable immunodeficiencyUlrich Salzer, Carla Neumann, Jens Thiel, et al.
Clinical Chemistry|February 4, 1999
Multicenter clinical and analytical evaluation of the AxSYM troponin-I immunoassay to assist in the diagnosis of myocardial infarctionF S Apple, A J Maturen, R E Mullins, et al.
Leukemia & Lymphoma|February 15, 2026
Chemotherapy regimens with second generation tyrosine kinase inhibitors for <i>BCR-ABL</i> B-cell acute lymphoblastic leukemia: comparative outcomes and role of allogeneic hematopoietic cell transplantationJohn Preston Claiborne, Hua-Ling Tsai, Gabriel Ghiaur, et al.
Molecular Neurodegeneration|May 9, 2020
Flow-cytometric microglial sorting coupled with quantitative proteomics identifies moesin as a highly-abundant microglial protein with relevance to Alzheimer's diseaseSruti Rayaprolu, Tianwen Gao, Hailian Xiao, et al.
Cancer Immunology, Immunotherapy : CII|January 26, 2020
First-in-human phase I clinical trial of the NY-ESO-1 protein cancer vaccine with NOD2 and TLR9 stimulants in patients with NY-ESO-1-expressing refractory solid tumorsMikiya Ishihara, Yasutaka Tono, Yoshihiro Miyahara, et al.
Journal of the American Heart Association|September 3, 2022
Mouse Model of Heart Failure With Preserved Ejection Fraction Driven by Hyperlipidemia and Enhanced Cardiac Low-Density Lipoprotein Receptor ExpressionMonique Williams, Jose Manuel Condor Capcha, Camila Iansen Irion, et al.
Leukemia & Lymphoma|February 6, 2023
Venetoclax in combination with hypomethylating agent for the treatment of advanced myeloproliferative neoplasms and acute myeloid leukemia with extramedullary diseaseKhaled Sanber, Kevin Ye, Hua-Ling Tsai, et al.
Pageof 100

Showing results (921-930 of 996) with videos related to

Sort By:
Pageof 100
Ejhaem|October 17, 2024
A phase 1 trial of venetoclax in combination with liposomal vincristine in patients with relapsed or refractory B-cell or T-cell acute lymphoblastic leukemia: Results from the ECOG-ACRIN EA9152 protocolNeil D Palmisiano, Ju-Whei Lee, David F Claxton, et al.
Current Oncology (Toronto, Ont.)|May 15, 2023
Integrating Tobacco Use Assessment and Treatment in the Oncology Setting: Quality Improvement Results from the Georgetown Lombardi Smoking Treatment and Recovery ProgramKathryn L Taylor, Marguerite A Webster, Joanna G Philips, et al.
Nature Biotechnology|June 4, 2002
Field and pulping performances of transgenic trees with altered lignificationGilles Pilate, Emma Guiney, Karen Holt, et al.
BMC Immunology|February 8, 2008
Screening of functional and positional candidate genes in families with common variable immunodeficiencyUlrich Salzer, Carla Neumann, Jens Thiel, et al.
Clinical Chemistry|February 4, 1999
Multicenter clinical and analytical evaluation of the AxSYM troponin-I immunoassay to assist in the diagnosis of myocardial infarctionF S Apple, A J Maturen, R E Mullins, et al.
Leukemia & Lymphoma|February 15, 2026
Chemotherapy regimens with second generation tyrosine kinase inhibitors for <i>BCR-ABL</i> B-cell acute lymphoblastic leukemia: comparative outcomes and role of allogeneic hematopoietic cell transplantationJohn Preston Claiborne, Hua-Ling Tsai, Gabriel Ghiaur, et al.
Molecular Neurodegeneration|May 9, 2020
Flow-cytometric microglial sorting coupled with quantitative proteomics identifies moesin as a highly-abundant microglial protein with relevance to Alzheimer's diseaseSruti Rayaprolu, Tianwen Gao, Hailian Xiao, et al.
Cancer Immunology, Immunotherapy : CII|January 26, 2020
First-in-human phase I clinical trial of the NY-ESO-1 protein cancer vaccine with NOD2 and TLR9 stimulants in patients with NY-ESO-1-expressing refractory solid tumorsMikiya Ishihara, Yasutaka Tono, Yoshihiro Miyahara, et al.
Journal of the American Heart Association|September 3, 2022
Mouse Model of Heart Failure With Preserved Ejection Fraction Driven by Hyperlipidemia and Enhanced Cardiac Low-Density Lipoprotein Receptor ExpressionMonique Williams, Jose Manuel Condor Capcha, Camila Iansen Irion, et al.
Leukemia & Lymphoma|February 6, 2023
Venetoclax in combination with hypomethylating agent for the treatment of advanced myeloproliferative neoplasms and acute myeloid leukemia with extramedullary diseaseKhaled Sanber, Kevin Ye, Hua-Ling Tsai, et al.
Pageof 100